Avista Capital acquires dental prosthetics provider Terrats Medical from Miura Partners

Avista Capital Partners (“Avista”), a leading healthcare-focused private equity firm, has announced its strategic acquisition of Terrats Medical (“Terrats”), a premier global provider of dental prosthetics, including abutments and implants. This acquisition from Miura Partners (“Miura”) signifies a pivotal advancement in the dental prosthetics market, underscoring Avista’s commitment to fostering innovation and growth within the healthcare sector.

Terrats Medical: Pioneering Global Excellence in Dental Prosthetics

Founded in 1947 and headquartered in Barcelona, Spain, Terrats Medical has distinguished itself as a key player in the dental industry. The company’s extensive product range, including high-quality dental abutments, implants, and related products, has set industry standards. Terrats’ compatibility with leading dental OEM implant systems demonstrates its commitment to versatility and quality, catering to a diverse clientele that includes dental offices, laboratories, and distributors worldwide. Notably, Terrats Medical has achieved significant international presence, with exports accounting for over 95% of its revenue, serving customers in more than 50 countries.

Strategic Initiatives and Growth Under Miura Partners

Since Miura Partners’ investment in 2020, Terrats Medical has embarked on an ambitious growth trajectory, tripling its sales through strategic initiatives such as enhancing direct sales under the DESS Dental Smart Solutions brand, expanding digital strategies, launching an implantology business, and acquiring distributors in the USA and Sweden. These efforts, coupled with key senior management hires, have positioned Terrats for continued success and innovation in the dental prosthetics market.

Avista’s Vision for Terrats Medical

With Avista’s acquisition, Terrats Medical is poised for a new phase of international growth, leveraging Avista’s deep knowledge of the US healthcare and specifically the dental market. Avista’s support will enable Terrats to reinforce its market presence in the US, explore expansion in other international markets, and seize new opportunities for inorganic growth. CEO Roger Terrats expressed enthusiasm for the partnership with Avista, highlighting the firm’s proven track record in the dental sector and its role in supporting Terrats’ global growth ambitions and product suite expansion.

Industry Perspectives and Future Outlook

The acquisition reflects a shared vision between Terrats Medical and Avista Capital Partners for advancing dental prosthetics through innovation, quality, and strategic growth. The dental industry, particularly the segment focusing on dental prosthetics, is poised for significant expansion, driven by increasing demand and technological advancements. Avista’s partnership with Terrats Medical is expected to catalyze further advancements in dental prosthetics, enhancing global access to high-quality dental solutions.